Sandoz Sees Aurobindo Deal Collapse As ‘Opportunity’

Termination Of $1bn Deal Will Allow Firm To ‘Optimize US Business’

 
• By David Wallace
  
Two_Doors
As one door closes, another one opens for Sandoz • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business